Fourth, AP2 loss gradually enhanced tumor growth in the panel of cell lines, from no effect (e.g. CFPAC-1) to a level on par with loss of the tumor suppressor PTEN (e.g. BXPC-3). This evidence concerns the gene PTEN and neoplasm.